TEVA PHARMACEUTICALS USA INC

Lobbying client · New Jersey · filed 2025 to 2026

$4,000,000 Reported spend

6 Filings counted

1 Firms hired

3 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (169003), not by name.

Firms hired 1

TEVA PHARMACEUTICALS USA, INC. $4,000,000 6 filings

Bills named in these filings 3

SJRES 37
A joint resolution terminating the national emergency declared to impose duties on articles imported from Can…

6 filings
HR 6888
Trump Tariff Transparency Act

3 filings
S 959
Tariff Transparency Act of 2025

3 filings

Reported by year 2 years

2026 $1,480,000 2 filings
2025 $2,520,000 4 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 9

Centers For Medicare and Medicaid Services (CMS) 6
Commerce, Dept of (DOC) 6
Executive Office of the President (EOP) 6
Food & Drug Administration (FDA) 6
Health & Human Services, Dept of (HHS) 6
Homeland Security, Dept of (DHS) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6
U.S. Trade Representative (USTR) 6

Recent filings 7 total

Q2

TEVA PHARMACEUTICALS USA, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $380,000 expenses · posted Jul 17, 2026

View → Q1

TEVA PHARMACEUTICALS USA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $1,100,000 expenses · posted Apr 20, 2026

View → Q4

TEVA PHARMACEUTICALS USA, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $360,000 expenses · posted Jan 14, 2026

View → Q3

TEVA PHARMACEUTICALS USA, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $460,000 expenses · posted Oct 17, 2025

View → 2A

TEVA PHARMACEUTICALS USA, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $1,390,000 expenses · posted Sep 4, 2025

View → Q2

TEVA PHARMACEUTICALS USA, INC. Amended

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $1,390,000 expenses · posted Jul 17, 2025

View → Q1

TEVA PHARMACEUTICALS USA, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $310,000 expenses · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.